JXSL2101107 | GSK3511294注射液 | depemokimab | Injection | Biological Products(1) | Import Drug Application | 2021-08-31 | | | | | view |
JXSL2000199 | GSK3511294注射液 | depemokimab | Injection | Biological Products(1) | Import Drug Application | 2020-11-07 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2020-11-06 | view |
JXSB2200071 | GSK3511294注射液 | depemokimab | Injection | Biological Products(1) | Supplementary Application | 2022-06-14 | | | | | view |
JXSB2101040 | GSK3511294注射液 | depemokimab | Injection | Biological Products(1) | Supplementary Application | 2021-07-28 | | | | | view |
JXSB2100030 | GSK3511294注射液 | depemokimab | Injection | Biological Products(1) | Supplementary Application | 2021-04-02 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2021-04-02 | view |